Dapagliflozin Impurity 19, with the CAS number 1469910-84-6, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent dapagliflozin, which is used primarily for the treatment of type 2 diabetes. As an impurity, it may arise during the synthesis or degradation of dapagliflozin and is typically characterized by its molecular structure, which includes specific functional groups that can influence its chemical behavior and stability. The compound's characteristics, such as solubility, melting point, and reactivity, are essential for understanding its impact on the overall quality and efficacy of the pharmaceutical formulation. Impurities like Dapagliflozin Impurity 19 are closely monitored in drug development and manufacturing processes to ensure safety and compliance with regulatory standards. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify such impurities in pharmaceutical products. Understanding the properties of impurities is crucial for maintaining the integrity of the active pharmaceutical ingredient and ensuring patient safety.

Dapagliflozin Impurity 19

1469910-84-6: Dapagliflozin Impurity 19, with the CAS number 1469910-84-6, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent dapagliflozin, which is used primarily for the treatment of type 2 diabetes. As an impurity, it may arise during the synthesis or degradation of dapagliflozin and is typically characterized by its molecular structure, which includes specific functional groups that can influence its chemical behavior and stability. The compound's characteristics, such as solubility, melting point, and reactivity, are essential for understanding its impact on the overall quality and efficacy of the pharmaceutical formulation. Impurities like Dapagliflozin Impurity 19 are closely monitored in drug development and manufacturing processes to ensure safety and compliance with regulatory standards. Analytical techniques such as chromatography and mass spectrometry are often employed to identify and quantify such impurities in pharmaceutical products. Understanding the properties of impurities is crucial for maintaining the integrity of the active pharmaceutical ingredient and ensuring patient safety.

CAS 1469910-84-6

Dapagliflozin Impurity 19

Dapagliflozin Impurity 96

Ref: 4Z-D-62105

Dapagliflozin Impurity 54

Ref: ST-EA-CP-D8116